Clinical Trial Update: Comparison of Clopidogrel Versus Ticagrelor Therapy for Atherosclerotic Plaque Inflammation [Phase 4]

View source ↗

Summary

Phase 4 trial comparing clopidogrel and ticagrelor for inflammation of atherosclerotic plaque has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis

Drugs mentioned

• BRILINTA (ticagrelor)
• Plavix (clopidogrel)

Snippet

Sponsor: CHEOL WHAN LEE, M.D., Ph.D | Conditions: Plaque, Atherosclerotic | Phase 4 | Status: COMPLETED